Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
How Does The Market Size Of The Gastroretentive Drug Delivery Systems Outsourcing Industry Compare Between 2025 And 2029?
The market for gastroretentive drug delivery systems outsourcing has seen robust expansion in recent years. This market is set to increase from $1.39 billion in 2024 to $1.49 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.5%. Key drivers for this historical growth include an escalating incidence of stomach and small intestine disorders, advancements in drug delivery systems, a higher prevalence of gastric cancer, an increase in government initiatives, and a greater number of hospitals.
The gastroretentive drug delivery systems outsourcing market is poised for significant expansion in the coming years. This market is forecasted to reach $1.98 billion by 2029, propelled by a compound annual growth rate (CAGR) of 7.4%. This projected growth stems from several factors, including an increase in ambulatory centers, a heightened focus on patient compliance and convenience, the rising occurrence of chronic diseases, the growth of personalized medicine, and an expanding aging population. Prominent trends for the forecast period involve advancements in polymer science, formulation technologies, bioadhesive systems, novel polymers, drug release modifiers, the evolution of gastroretentive dosage forms, the integration of digital health technologies, smart gastroretentive systems, and targeted drug delivery.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15813&type=smp
What Are The Key Drivers Of Growth In The Gastroretentive Drug Delivery Systems Outsourcing Market?
The increasing occurrence of gastrointestinal disorders is projected to propel the expansion of the gastroretentive drug delivery systems outsourcing market in the coming years. These disorders encompass a broad spectrum of diseases that affect the digestive tract, including the stomach, liver, gallbladder, intestines, and pancreas. The rise in gastrointestinal disorders is attributed to factors such as aging populations, antibiotic use, infectious agents, dietary shifts, stress, various lifestyle factors, and obesity. Outsourcing gastroretentive drug delivery systems offers pharmaceutical companies the necessary resources and specialized knowledge to address the escalating burden of these conditions, ultimately enhancing patient outcomes and their quality of life. For instance, in January 2023, the American Cancer Society (ACS), a US-based health organization dedicated to eliminating cancer, reported that gastrointestinal cancers increased by 3.18% to 348,840 cases in the United States, up from 338,090 in 2021. Thus, the growing prevalence of gastrointestinal disorders is significantly driving the gastroretentive drug delivery systems outsourcing market.
What Are The Different Segment Classifications Within The Gastroretentive Drug Delivery Systems Outsourcing Market?
The gastroretentive drug delivery systems outsourcingmarket covered in this report is segmented –
1) By Type: Floating Systems; Bioadhesive Systems; Other Types
2) By Dosage Form: Tablets; Liquid; Microspheres; Capsule; Other Dosage Forms
3) By Application: Gastroesophageal Reflux Disease (GERD); Neurological Disorders; Other Applications
4) By End User: Pharmaceutical Companies; Contract Research Organizations (CROs); Other End Users
Subsegments:
1) Floating Systems: Single Unit Systems; Multiple Unit Systems
2) Bioadhesive Systems: Hydrogels; Mucoadhesive Polymers
3) Other Types: Magnetically Assisted Systems; High-Density Systems; Osmotic Systems
How Are Trends Influencing The Gastroretentive Drug Delivery Systems Outsourcing Market?
Major companies within the gastroretentive drug delivery systems outsourcing market are concentrating on creating innovative products, such as ready-to-fill (RTF) colon functional capsules, to boost drug delivery efficiency and patient ease. Ready-to-fill (RTF) colon functional capsules refer to pre-manufactured, empty capsules specifically designed to be filled with particular formulations or active ingredients tailored for the colon. For instance, in September 2024, Evonik, a Germany-based leader in advanced drug delivery, unveiled EUDRACAP colon functional capsules, engineered for the targeted administration of oral drugs to the ileo-colonic region. These innovative capsules are the first ready-to-fill option introduced to the market, intended for delivering sensitive active ingredients like live biotherapeutic products (LBPs). Currently available in technical grade, a GMP-grade product is also being developed. EUDRACAP colon improves the oral drug development process by simplifying formulation and expediting time to market, positioning it as a significant stride in gastroretentive drug delivery systems.
Which Major Industry Participants Are Leading The Gastroretentive Drug Delivery Systems Outsourcing Market Growth?
Major companies operating in the gastroretentive drug delivery systems outsourcing market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Sanofi S.A., AstraZeneca plc, Novartis AG, GlaxoSmithKline plc, Evonik Industries AG, Alcon Inc., SGS SA, Lonza Group AG, FMC Corporation, Sun Pharmaceutical Industries Ltd., Catalent Inc., AptarGroup Inc., Cadila Pharmaceuticals, Ashland Global Holdings Inc., Lupin Limited, Torrent Pharmaceuticals Ltd., Evotec SE, Colorcon Inc., Ranbaxy Laboratories Limited, Quotient Sciences Limited, Aenova Group, Vectura Group Ltd., Assertio Therapeutics Inc., Coating Place Inc., Xiromed LLC, SPI Pharma Inc.
Download The Full Report For Exclusive Market Findings:
Which Geographies Are Emerging As Strong Markets For The Gastroretentive Drug Delivery Systems Outsourcing Industry?
North America was the largest region in the gastroretentive drug delivery systems outsourcing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastroretentive drug delivery systems outsourcing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Request A Customized Version Of The Gastroretentive Drug Delivery Systems Outsourcing Market Report:
https://www.thebusinessresearchcompany.com/customise?id=15813&type=smp
Browse Through More Reports Similar to the Global Gastroretentive Drug Delivery Systems Outsourcing Market 2025, By The Business Research Company
Gastric Cancer Drugs Global Market 2025
https://www.thebusinessresearchcompany.com/report/gastric-cancer-drugs-global-market
Gastrointestinal Drug Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/gastrointestinal-drug-global-market-report
Nasal Drug Delivery Technology Global Market Report 2025
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model